Gated intracoronary thallium201 scintigraphy: feasibility and potential clinical advantages.
Visualization of ventricular walls with true global motion and myocardial thickening is not possible with use of present scintigraphic techniques. When thallium 201 (201TI) is injected intravenously (IV), only about 5% reaches the myocardium. However, if 201TI is injected intracoronarily, 100% reaches, and approximately 88% localizes in, the myocardium, which results in higher count rates than when given IV, permitting acceptable acquisition times for gated true wall motion studies. The authors describe a new technique using intracoronary (IC) 201TI to acquire high count rate, high contrast, and short acquisition time in gated true wall motion studies. Thirteen patients were studied at rest with gated IC thallium. Six of these patients also had resting IV 201TI myocardial studies. After routine coronary angiography, 0.75 mCi of 201TI was injected into each coronary artery. Multiple sequential one-minute gated studies were obtained in LAO and RAO projections, followed by sequential five-minute images for two hours to determine 201TI redistribution kinetics. Regions of interest over segments of left and right ventricles and background permitted definition of temporal and spatial distributions. Three one-minute gated studies were summed with a total count of 2,100 K for a three-minute acquisition. Myocardium-to-background ratios were as high as 13:1 with a mean of 11.4:1 in the IC study compared with 2.3:1 in the IV studies. Washout half-time in normal myocardium was 95 +/- 5 min. The detectability and size of perfusion defects were different on gated diastolic and systolic, nongated, and IV studies. Questionable defects seen on nongated studies or after IV administration were easily noted on gated diastolic images.(ABSTRACT TRUNCATED AT 250 WORDS)
Siegel
M E
ME
Division of Nuclear Medicine, University of Southern California, Los Angeles.
Chen
D C
DC
Lee
K
K
Rasmussen
D
D
Colletti
P
P
Thom
P
P
Rahimtoola
S H
SH
D003331:Coronary Vessels; D006321:Heart / Q000000981:diagnostic imaging*; D006801:Humans; D007089:Image Enhancement; D007269:Injections, Intra-Arterial; D009200:Myocardial Contraction; D011877:Radionuclide Imaging; D013794:Thallium Radioisotopes / Q000008:administration & dosage*
D013794:Thallium Radioisotopes